List of Excipients in API PRAZIQUANTEL
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing PRAZIQUANTEL
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | CELLULOSE, MICROCRYSTALLINE | |
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | CROSPOVIDONE | |
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | HYPROMELLOSE | |
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | MAGNESIUM STEARATE | |
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | POLYETHYLENE GLYCOL | |
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | SODIUM LAURYL SULFATE | |
| Bayer HealthCare Pharmaceuticals Inc | BILTRICIDE | praziquantel | 50419-747 | STARCH, CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 7 of 7 entries
Excipients in ANDA-approved (generic) drugs containing PRAZIQUANTEL
Showing 1 to 7 of 7 entries
Detailed excipient profiles for PRAZIQUANTEL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
PRAZIQUANTEL drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
PRAZIQUANTEL drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: CROSCARMELLOSE SODIUM
PRAZIQUANTEL drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
PRAZIQUANTEL drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
Excipient focus: CROSPOVIDONE
PRAZIQUANTEL drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
PRAZIQUANTEL drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
Excipient focus: HYPROMELLOSE
PRAZIQUANTEL drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
PRAZIQUANTEL drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: HYPROMELLOSE 2208
PRAZIQUANTEL drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
PRAZIQUANTEL drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
Excipient focus: MAGNESIUM STEARATE
PRAZIQUANTEL drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
PRAZIQUANTEL drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: POLYETHYLENE GLYCOL
PRAZIQUANTEL drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
PRAZIQUANTEL drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: POLYETHYLENE GLYCOL 1000
PRAZIQUANTEL drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
PRAZIQUANTEL drug variants not containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
Excipient focus: POVIDONE
PRAZIQUANTEL drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
PRAZIQUANTEL drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: SODIUM LAURYL SULFATE
PRAZIQUANTEL drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
PRAZIQUANTEL drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: STARCH, CORN
PRAZIQUANTEL drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
PRAZIQUANTEL drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: TITANIUM DIOXIDE
PRAZIQUANTEL drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | praziquantel | 49884-231 |
| Bayer HealthCare Pharmaceuticals Inc | praziquantel | 50419-747 |
| Central Texas Community Health Centers | praziquantel | 76413-146 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
PRAZIQUANTEL drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
